Skip to main content
Premium Trial:

Request an Annual Quote

LSBC s Revenues Take Dive, Losses Narrow in Q1

NEWS YORK, April 30 (GenomeWeb News) - Large Scale Biology reported a sharp decline in revenues as well as narrowed losses for the first quarter of 2004 on Wednesday.

 

The company's revenues totaled $320,000, down from $850,000 during the same quarter last year.

 

Research and development costs were $2.2 million, down from $3.2 million during the same period a year ago.

 

LSBC's net loss amounted to $4.3 million, or $.16 per share, down from $7.6 million, or $.3 per share, during the year-ago period.

 

As of March 31, LSBC had $11.2 million in cash and marketable securities.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.